Previous real-world studies in Italy have examined diabetes-related outcomes related to GLP-1 RAs [25–27]; this is the first published study evaluating the real-world treatment patterns of individual GLP-1 RAs in Italy. The gene discussed is GLP1R; the disease is diabetes mellitus.